Sitacip D 5mg/50mg Tablet
Marketer
Cipla Ltd
Salt Composition
Dapagliflozin (5mg) + Sitagliptin (50mg)
Overview Sitacip D 5mg/50mg Tablet
Diabetic patients can manage their blood glucose with the combined medication Sitacip D 5mg/50mg. This tablet, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It improves insulin effectiveness, thus reducing blood sugar. Sitacip D 5mg/50mg can be administered with or without food, but consistent daily timing is recommended. Dosage is determined by your physician; discontinuation requires their approval, as abrupt cessation can elevate blood sugar, risking complications like kidney disease and vision loss. This medication complements a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and potential weight management, all guided by your doctor. Common side effects include upper respiratory tract infections, nasal congestion, sore throat, and urinary tract infections. Hydration is key to mitigating dehydration. Genital fungal infections are a possibility; diligent hygiene minimizes this risk. Prior to use, disclose kidney or liver issues, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical counsel before commencing treatment. Limit alcohol consumption to reduce potential adverse effects. Regular blood sugar monitoring is crucial while using this medication.
Uses of Sitacip D 5mg/50mg Tablet
Managing Type 2 diabetes
Major Benefits of Sitacip D 5mg/50mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitacip D 5mg/50mg Tablet whole; avoid crushing, chewing, or breaking it. This medication can be taken with or without food, though consistent timing is recommended.
Common Side effects of Sitacip D 5mg/50mg Tablet:
- Vaginal yeast infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Upper respiratory tract infection
- Headache
How to use Sitacip D 5mg/50mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sitacip D 5mg/50mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Sitacip D 5mg/50mg Tablet works:
Sitacip D 5mg/50mg tablets combine dapagliflozin and sitagliptin to manage blood sugar. Dapagliflozin works by enhancing glucose elimination through urine, thereby lowering blood glucose. Sitagliptin's action involves decreasing liver glucose production via increased insulin and reduced glucagon, a hormone that elevates blood sugar.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between alcohol and Sitacip D 5mg/50mg Tablet is undefined regarding safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Sitacip D 5mg/50mg Tablet in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Sitacip D 5mg/50mg Tablet with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Sitacip D 5mg/50mg Tablet's effect on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Sitacip D 5mg/50mg Tablet use in individuals with renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Data regarding Sitacip D 5mg/50mg Tablet use in individuals with hepatic impairment is scarce. Seek medical advice from your physician.
What if you forget to take Sitacip D 5mg/50mg Tablet :
Should you forget to take a Sitacip D 5mg/50mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sitacip D 5mg/50mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |





